What does elevated hemoglobin and hematocrit indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Elevated Hemoglobin and Hematocrit in a 61-Year-Old Female

The elevated red blood cell count (5.51), hemoglobin (18.8), hematocrit (54.8), and MCV (99.5) in a 61-year-old female strongly indicate polycythemia that requires immediate evaluation for underlying causes, particularly polycythemia vera, which can significantly increase risk of thrombotic events and mortality if left untreated. 1

Interpretation of Laboratory Values

Your laboratory values show:

  • RBC: 5.51 (elevated)
  • Hemoglobin: 18.8 g/dL (significantly elevated)
  • Hematocrit: 54.8% (significantly elevated)
  • MCV: 99.5 fL (high normal/slightly elevated)
  • MCHC: 34.1 g/dL (normal)

These values demonstrate erythrocytosis (increased red blood cell mass), which is defined as a hematocrit >48% in women according to current guidelines 1. The elevated MCV suggests a macrocytic tendency, which can be seen in certain forms of polycythemia.

Diagnostic Algorithm

Step 1: Determine if this is absolute or relative polycythemia

  • Your hematocrit of 54.8% exceeds the threshold for absolute polycythemia in women (>48%) 1
  • The combination of elevated hemoglobin, hematocrit, and RBC count strongly suggests absolute polycythemia rather than relative polycythemia (which would be due to plasma volume depletion) 2

Step 2: Differentiate between primary and secondary polycythemia

Primary causes:

  • Polycythemia vera (PV) - a myeloproliferative neoplasm

Secondary causes:

  • Hypoxia-driven: Chronic lung disease, sleep apnea, high altitude, smoking
  • Non-hypoxia driven: Tumors producing erythropoietin, kidney disease, exogenous testosterone or androgen use 1

Step 3: Recommended diagnostic workup

  1. Serum erythropoietin (EPO) level - Low in PV, normal/elevated in secondary causes 1
  2. JAK2 V617F mutation testing - Present in >95% of PV cases 1
  3. JAK2 exon 12 testing - If JAK2 V617F is negative but PV still suspected 1
  4. Oxygen saturation and arterial blood gas - To assess for hypoxic causes
  5. Abdominal ultrasound - To check for splenomegaly (common in PV) 2

Important Clinical Considerations

Potential Causes to Consider

  1. Polycythemia vera - A primary bone marrow disorder that should be strongly suspected given your significantly elevated values 1
  2. Exogenous testosterone or androgen use - Can cause significant erythrocytosis in women 3, 4
  3. Chronic hypoxic conditions - Such as undiagnosed sleep apnea or COPD 1
  4. Smoking - The most common cause of secondary polycythemia 2
  5. Kidney disease or renal tumors - Can cause inappropriate EPO production 1

Risk Implications

  • Thrombotic events - Elevated hematocrit increases blood viscosity and significantly raises risk of stroke, myocardial infarction, and venous thromboembolism 1
  • Hyperviscosity symptoms - Headache, dizziness, visual disturbances, and fatigue may occur 1

Management Considerations

If polycythemia vera is confirmed:

  • Therapeutic phlebotomy to maintain hematocrit <45% (or appropriate level for women) 1
  • Low-dose aspirin (81-100 mg daily) to reduce thrombotic risk 1
  • Cytoreductive therapy (hydroxyurea or interferon-alfa) for high-risk patients 1

If secondary polycythemia is identified:

  • Treatment of the underlying cause
  • Phlebotomy may still be needed to reduce thrombotic risk 4

Common Pitfalls to Avoid

  • Overlooking secondary causes - Comprehensive evaluation is necessary before concluding PV diagnosis 5
  • Assuming blood donation alone is sufficient - Studies show that blood donation may not adequately control hematocrit in patients with persistent erythrocytosis 4
  • Delaying diagnosis - These significantly elevated values warrant prompt evaluation due to increased thrombotic risk 1

The macrocytosis (elevated MCV) in your case adds another dimension requiring investigation, as it may suggest vitamin B12 or folate deficiency, liver disease, or could be related to a myeloproliferative disorder itself 1.

References

Guideline

Diagnosis and Management of Polycythemia Vera

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Elevated Hemoglobin--polyglobulia or polycythemia?].

MMW Fortschritte der Medizin, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.